Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease
- PMID: 2598982
- DOI: 10.1007/BF00558121
Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease
Abstract
The haemodynamic effects of oral nifedipine 20 mg and molsidomine 4 mg were compared in 24 patients with coronary artery disease. Molsidomine unlike nifedipine caused a significant fall in mean pulmonary artery pressure and left ventricular end-diastolic pressure. Both drugs caused a significant and comparable reduction in systolic and diastolic blood pressure. Although only nifedipine significantly reduced systemic vascular resistance the difference between the drugs was not significant. The heart rate was significantly increased by nifedipine but not by molsidomine. The ejection phase indices were all increased by molsidomine and the increment in the mean normalized systolic ejection rate was significantly greater than that due to nifedipine. The left ventricular end-systolic volume index decreased significantly after molsidomine but not nifedipine. Neither drug significantly affected left ventricular end diastolic volume index, stroke volume index, maximal rate of rise of left ventricular pressure or left ventricular stroke work index.
Similar articles
-
Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?Cardiovasc Drugs Ther. 1988 May;2(1):79-82. doi: 10.1007/BF00054256. Cardiovasc Drugs Ther. 1988. PMID: 3154698 Clinical Trial.
-
Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.Am Heart J. 1985 Mar;109(3 Pt 2):649-53. doi: 10.1016/0002-8703(85)90672-6. Am Heart J. 1985. PMID: 3838401 Clinical Trial.
-
[Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].Arch Mal Coeur Vaiss. 1984 Nov;77(12):1383-9. Arch Mal Coeur Vaiss. 1984. PMID: 6150693 French.
-
Molsidomine: alternative approaches to treat myocardial ischemia.Pharmacotherapy. 1987 Jan-Feb;7(1):28-37. doi: 10.1002/j.1875-9114.1987.tb03503.x. Pharmacotherapy. 1987. PMID: 3554158 Review.
-
New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects.Trends Pharmacol Sci. 1989 Oct;10(10):397-400. doi: 10.1016/0165-6147(89)90187-9. Trends Pharmacol Sci. 1989. PMID: 2694536 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources